Global Diabetes Testing Program Market Insights, Forecast to 2030

Description

List of Tables

The global Diabetes Testing Program market is projected to grow from US$ 2,504.20 million in 2024 to US$ 3,872.15 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period.

The United States & Canada market for Diabetes Testing Program is estimated to increase from $ 503.02 million in 2024 to reach $ 769.48 million by 2030, at a CAGR of 7.34% during the forecast period of 2025 through 2030.

The China market for Diabetes Testing Program is estimated to increase from $ 842.84 million in 2024 to reach $ 1,337.16 million by 2030, at a CAGR of 8.00% during the forecast period of 2025 through 2030.

The Europe market for Diabetes Testing Program is estimated to increase from $ 312.03 million in 2024 to reach $ 447.37 million by 2030, at a CAGR of 6.19% during the forecast period of 2025 through 2030.

The global key manufacturers of Diabetes Testing Program include Abbott Laboratories, Roche, Siemens, LifeScan, Bio-Rad Laboratories, etc. In 2023, the global top five players had a share approximately 64.41% in terms of revenue.

Report Includes

This report presents an overview of global market for Diabetes Testing Program, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Diabetes Testing Program, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diabetes Testing Program, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetes Testing Program sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetes Testing Program market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Diabetes Testing Program sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche, LifeScan, Abbott Laboratories, Ascensia, Arkray, I-SENS, Omron, Braun, and Siemens, etc.

Market Segmentation

By Company

Abbott Laboratories
Roche
Siemens
LifeScan
Bio-Rad Laboratories
Sinocare
Tosoh
Ascensia
Danaher Corporation
Trinity Biotech
Acon Biotech
Terumo
Arkray
HUMAN Diagnostics
Braun
I-SENS
Omron

Segment by Type

HbA1c Test
Finger-prick Test

Segment by Application

Medical Diagnosis
Home Test
Lab Testing

Segment by Region

US & Canada

U.S.
Canada

China

Asia (excluding China)

Japan
South Korea
Southeast Asia
India
Australia

Europe

Germany
France
U.K.
Italy
Russia

Middle East, Africa, Latin America

Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Diabetes Testing Program in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Diabetes Testing Program manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Testing Program sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

1 STUDY COVERAGE

1.1 Diabetes Testing Program Product Introduction
1.2 Market by Type
- 1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
- 1.2.2 HbA1c Test
- 1.2.3 Finger-prick Test
1.3 Market by Application
- 1.3.1 Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
- 1.3.2 Medical Diagnosis
- 1.3.3 Home Test
- 1.3.4 Lab Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Diabetes Testing Program Revenue Estimates and Forecasts 2019-2030
2.2 Global Diabetes Testing Program Revenue by Region
- 2.2.1 Global Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030
- 2.2.2 Global Diabetes Testing Program Revenue by Region (2019-2024)
- 2.2.3 Global Diabetes Testing Program Revenue by Region (2025-2030)
- 2.2.4 Global Diabetes Testing Program Revenue Market Share by Region (2019-2030)
2.3 Global Diabetes Testing Program Sales Estimates and Forecasts 2019-2030
2.4 Global Diabetes Testing Program Sales by Region
- 2.4.1 Global Diabetes Testing Program Sales by Region: 2019 VS 2023 VS 2030
- 2.4.2 Global Diabetes Testing Program Sales by Region (2019-2024)
- 2.4.3 Global Diabetes Testing Program Sales by Region (2025-2030)
- 2.4.4 Global Diabetes Testing Program Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

3.1 Global Diabetes Testing Program Sales by Manufacturers
- 3.1.1 Global Diabetes Testing Program Sales by Manufacturers (2019-2024)
- 3.1.2 Global Diabetes Testing Program Sales Market Share by Manufacturers (2019-2024)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetes Testing Program in 2023
3.2 Global Diabetes Testing Program Revenue by Manufacturers
- 3.2.1 Global Diabetes Testing Program Revenue by Manufacturers (2019-2024)
- 3.2.2 Global Diabetes Testing Program Revenue Market Share by Manufacturers (2019-2024)
- 3.2.3 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2023
3.3 Global Key Players of Diabetes Testing Program, Industry Ranking, 2021 VS 2022
3.4 Global Diabetes Testing Program Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
- 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.5.2 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Diabetes Testing Program, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Diabetes Testing Program, Product Offered
3.8 Global Key Manufacturers of Diabetes Testing Program, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

4.1 Global Diabetes Testing Program Sales by Type
- 4.1.1 Global Diabetes Testing Program Historical Sales by Type (2019-2024)
- 4.1.2 Global Diabetes Testing Program Forecasted Sales by Type (2025-2030)
- 4.1.3 Global Diabetes Testing Program Sales Market Share by Type (2019-2030)
4.2 Global Diabetes Testing Program Revenue by Type
- 4.2.1 Global Diabetes Testing Program Historical Revenue by Type (2019-2024)
- 4.2.2 Global Diabetes Testing Program Forecasted Revenue by Type (2025-2030)
- 4.2.3 Global Diabetes Testing Program Revenue Market Share by Type (2019-2030)
4.3 Global Diabetes Testing Program Price by Type
- 4.3.1 Global Diabetes Testing Program Price by Type (2019-2024)
- 4.3.2 Global Diabetes Testing Program Price Forecast by Type (2025-2030)

5 MARKET SIZE BY APPLICATION

5.1 Global Diabetes Testing Program Sales by Application
- 5.1.1 Global Diabetes Testing Program Historical Sales by Application (2019-2024)
- 5.1.2 Global Diabetes Testing Program Forecasted Sales by Application (2025-2030)
- 5.1.3 Global Diabetes Testing Program Sales Market Share by Application (2019-2030)
5.2 Global Diabetes Testing Program Revenue by Application
- 5.2.1 Global Diabetes Testing Program Historical Revenue by Application (2019-2024)
- 5.2.2 Global Diabetes Testing Program Forecasted Revenue by Application (2025-2030)
- 5.2.3 Global Diabetes Testing Program Revenue Market Share by Application (2019-2030)
5.3 Global Diabetes Testing Program Price by Application
- 5.3.1 Global Diabetes Testing Program Price by Application (2019-2024)
- 5.3.2 Global Diabetes Testing Program Price Forecast by Application (2025-2030)

6 US & CANADA

6.1 US & Canada Diabetes Testing Program Market Size by Type
- 6.1.1 US & Canada Diabetes Testing Program Sales by Type (2019-2030)
- 6.1.2 US & Canada Diabetes Testing Program Revenue by Type (2019-2030)
6.2 US & Canada Diabetes Testing Program Market Size by Application
- 6.2.1 US & Canada Diabetes Testing Program Sales by Application (2019-2030)
- 6.2.2 US & Canada Diabetes Testing Program Revenue by Application (2019-2030)
6.3 US & Canada Diabetes Testing Program Market Size by Country
- 6.3.1 US & Canada Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030
- 6.3.2 US & Canada Diabetes Testing Program Revenue by Country (2019-2030)
- 6.3.3 US & Canada Diabetes Testing Program Sales by Country (2019-2030)
- 6.3.4 US
- 6.3.5 Canada

7 EUROPE

7.1 Europe Diabetes Testing Program Market Size by Type
- 7.1.1 Europe Diabetes Testing Program Sales by Type (2019-2030)
- 7.1.2 Europe Diabetes Testing Program Revenue by Type (2019-2030)
7.2 Europe Diabetes Testing Program Market Size by Application
- 7.2.1 Europe Diabetes Testing Program Sales by Application (2019-2030)
- 7.2.2 Europe Diabetes Testing Program Revenue by Application (2019-2030)
7.3 Europe Diabetes Testing Program Market Size by Country
- 7.3.1 Europe Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030
- 7.3.2 Europe Diabetes Testing Program Revenue by Country (2019-2030)
- 7.3.3 Europe Diabetes Testing Program Sales by Country (2019-2030)
- 7.3.4 Germany
- 7.3.5 France
- 7.3.6 U.K.
- 7.3.7 Italy
- 7.3.8 Russia

8 CHINA

8.1 China Diabetes Testing Program Market Size by Type
- 8.1.1 China Diabetes Testing Program Sales by Type (2019-2030)
- 8.1.2 China Diabetes Testing Program Revenue by Type (2019-2030)
8.2 China Diabetes Testing Program Market Size by Application
- 8.2.1 China Diabetes Testing Program Sales by Application (2019-2030)
- 8.2.2 China Diabetes Testing Program Revenue by Application (2019-2030)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Diabetes Testing Program Market Size by Type
- 9.1.1 Asia Diabetes Testing Program Sales by Type (2019-2030)
- 9.1.2 Asia Diabetes Testing Program Revenue by Type (2019-2030)
9.2 Asia Diabetes Testing Program Market Size by Application
- 9.2.1 Asia Diabetes Testing Program Sales by Application (2019-2030)
- 9.2.2 Asia Diabetes Testing Program Revenue by Application (2019-2030)
9.3 Asia Diabetes Testing Program Market Size by Region
- 9.3.1 Asia Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030
- 9.3.2 Asia Diabetes Testing Program Revenue by Region (2019-2030)
- 9.3.3 Asia Diabetes Testing Program Sales by Region (2019-2030)
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 Southeast Asia
- 9.3.7 India
- 9.3.8 Australia

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

10.1 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Type
- 10.1.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2019-2030)
- 10.1.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Application
- 10.2.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2019-2030)
- 10.2.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Country
- 10.3.1 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030
- 10.3.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2019-2030)
- 10.3.3 Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2019-2030)
- 10.3.4 Brazil
- 10.3.5 Mexico
- 10.3.6 Turkey
- 10.3.7 Israel
- 10.3.8 GCC Countries

11 CORPORATE PROFILE

11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Information
- 11.1.2 Abbott Laboratories Overview
- 11.1.3 Abbott Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.1.4 Abbott Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Abbott Laboratories Recent Developments
11.2 Roche
- 11.2.1 Roche Company Information
- 11.2.2 Roche Overview
- 11.2.3 Roche Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.2.4 Roche Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Roche Recent Developments
11.3 Siemens
- 11.3.1 Siemens Company Information
- 11.3.2 Siemens Overview
- 11.3.3 Siemens Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.3.4 Siemens Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Siemens Recent Developments
11.4 LifeScan
- 11.4.1 LifeScan Company Information
- 11.4.2 LifeScan Overview
- 11.4.3 LifeScan Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
11.5 Bio-Rad Laboratories
- 11.5.1 Bio-Rad Laboratories Company Information
- 11.5.2 Bio-Rad Laboratories Overview
- 11.5.3 Bio-Rad Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.5.4 Bio-Rad Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Bio-Rad Laboratories Recent Developments
11.6 Sinocare
- 11.6.1 Sinocare Company Information
- 11.6.2 Sinocare Overview
- 11.6.3 Sinocare Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.6.4 Sinocare Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
11.7 Tosoh
- 11.7.1 Tosoh Company Information
- 11.7.2 Tosoh Overview
- 11.7.3 Tosoh Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.7.4 Tosoh Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Tosoh Recent Developments
11.8 Ascensia
- 11.8.1 Ascensia Company Information
- 11.8.2 Ascensia Overview
- 11.8.3 Ascensia Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.8.4 Ascensia Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
11.9 Danaher Corporation
- 11.9.1 Danaher Corporation Company Information
- 11.9.2 Danaher Corporation Overview
- 11.9.3 Danaher Corporation Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.9.4 Danaher Corporation Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Danaher Corporation Recent Developments
11.10 Trinity Biotech
- 11.10.1 Trinity Biotech Company Information
- 11.10.2 Trinity Biotech Overview
- 11.10.3 Trinity Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.10.4 Trinity Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Trinity Biotech Recent Developments
11.11 Acon Biotech
- 11.11.1 Acon Biotech Company Information
- 11.11.2 Acon Biotech Overview
- 11.11.3 Acon Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.11.4 Acon Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
11.12 Terumo
- 11.12.1 Terumo Company Information
- 11.12.2 Terumo Overview
- 11.12.3 Terumo Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.12.4 Terumo Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.12.5 Terumo Recent Developments
11.13 Arkray
- 11.13.1 Arkray Company Information
- 11.13.2 Arkray Overview
- 11.13.3 Arkray Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.13.4 Arkray Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
11.14 HUMAN Diagnostics
- 11.14.1 HUMAN Diagnostics Company Information
- 11.14.2 HUMAN Diagnostics Overview
- 11.14.3 HUMAN Diagnostics Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.14.4 HUMAN Diagnostics Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
11.15 Braun
- 11.15.1 Braun Company Information
- 11.15.2 Braun Overview
- 11.15.3 Braun Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.15.4 Braun Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.15.5 Braun Recent Developments
11.16 I-SENS
- 11.16.1 I-SENS Company Information
- 11.16.2 I-SENS Overview
- 11.16.3 I-SENS Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.16.4 I-SENS Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.16.5 I-SENS Recent Developments
11.17 Omron
- 11.17.1 Omron Company Information
- 11.17.2 Omron Overview
- 11.17.3 Omron Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.17.4 Omron Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
- 11.17.5 Omron Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

12.1 Diabetes Testing Program Industry Chain Analysis
12.2 Diabetes Testing Program Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Diabetes Testing Program Production Mode & Process
12.4 Diabetes Testing Program Sales and Marketing
- 12.4.1 Diabetes Testing Program Sales Channels
- 12.4.2 Diabetes Testing Program Distributors
12.5 Diabetes Testing Program Customers

13 DIABETES TESTING PROGRAM MARKET DYNAMICS

13.1.1 Diabetes Testing Program Industry Trends
13.1.2 Diabetes Testing Program Market Drivers
13.1.3 Diabetes Testing Program Market Challenges
13.1.4 Diabetes Testing Program Market Restraints

14 KEY FINDINGS IN THE GLOBAL DIABETES TESTING PROGRAM STUDY

15 APPENDIX

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables

Table 1. Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Finger-prick Test
Table 3. Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 4. Global Diabetes Testing Program Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Diabetes Testing Program Revenue by Region (2019-2024) & (US$ Million)
Table 6. Global Diabetes Testing Program Revenue by Region (2025-2030) & (US$ Million)
Table 7. Global Diabetes Testing Program Revenue Market Share by Region (2019-2024)
Table 8. Global Diabetes Testing Program Revenue Market Share by Region (2025-2030)
Table 9. Global Diabetes Testing Program Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 10. Global Diabetes Testing Program Sales by Region (2019-2024) & (K Units)
Table 11. Global Diabetes Testing Program Sales by Region (2025-2030) & (K Units)
Table 12. Global Diabetes Testing Program Sales Market Share by Region (2019-2024)
Table 13. Global Diabetes Testing Program Sales Market Share by Region (2025-2030)
Table 14. Global Diabetes Testing Program Sales by Manufacturers (2019-2024) & (K Units)
Table 15. Global Diabetes Testing Program Sales Share by Manufacturers (2019-2024)
Table 16. Global Diabetes Testing Program Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 17. Global Diabetes Testing Program Revenue Market Share by Manufacturers (2019-2024)
Table 18. Global Key Players of Diabetes Testing Program, Industry Ranking, 2021 VS 2022
Table 19. Diabetes Testing Program Price by Manufacturers (2019-2024) & (US$/Unit)
Table 20. Global Diabetes Testing Program Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Diabetes Testing Program by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Testing Program as of 2023)
Table 22. Global Key Manufacturers of Diabetes Testing Program, Manufacturing Base Distribution and Headquarters
Table 23. Global Key Manufacturers of Diabetes Testing Program, Product Offered
Table 24. Global Key Manufacturers of Diabetes Testing Program, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Diabetes Testing Program Sales by Type (2019-2024) & (K Units)
Table 27. Global Diabetes Testing Program Sales by Type (2025-2030) & (K Units)
Table 28. Global Diabetes Testing Program Sales Share by Type (2019-2024)
Table 29. Global Diabetes Testing Program Sales Share by Type (2025-2030)
Table 30. Global Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million)
Table 31. Global Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million)
Table 32. Global Diabetes Testing Program Revenue Share by Type (2019-2024)
Table 33. Global Diabetes Testing Program Revenue Share by Type (2025-2030)
Table 34. Diabetes Testing Program Price by Type (2019-2024) & (US$/Unit)
Table 35. Global Diabetes Testing Program Price Forecast by Type (2025-2030) & (US$/Unit)
Table 36. Global Diabetes Testing Program Sales by Application (2019-2024) & (K Units)
Table 37. Global Diabetes Testing Program Sales by Application (2025-2030) & (K Units)
Table 38. Global Diabetes Testing Program Sales Share by Application (2019-2024)
Table 39. Global Diabetes Testing Program Sales Share by Application (2025-2030)
Table 40. Global Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million)
Table 41. Global Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million)
Table 42. Global Diabetes Testing Program Revenue Share by Application (2019-2024)
Table 43. Global Diabetes Testing Program Revenue Share by Application (2025-2030)
Table 44. Diabetes Testing Program Price by Application (2019-2024) & (US$/Unit)
Table 45. Global Diabetes Testing Program Price Forecast by Application (2025-2030) & (US$/Unit)
Table 46. US & Canada Diabetes Testing Program Sales by Type (2019-2024) & (K Units)
Table 47. US & Canada Diabetes Testing Program Sales by Type (2025-2030) & (K Units)
Table 48. US & Canada Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million)
Table 49. US & Canada Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million)
Table 50. US & Canada Diabetes Testing Program Sales by Application (2019-2024) & (K Units)
Table 51. US & Canada Diabetes Testing Program Sales by Application (2025-2030) & (K Units)
Table 52. US & Canada Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million)
Table 53. US & Canada Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million)
Table 54. US & Canada Diabetes Testing Program Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 55. US & Canada Diabetes Testing Program Revenue by Country (2019-2024) & (US$ Million)
Table 56. US & Canada Diabetes Testing Program Revenue by Country (2025-2030) & (US$ Million)
Table 57. US & Canada Diabetes Testing Program Sales by Country (2019-2024) & (K Units)
Table 58. US & Canada Diabetes Testing Program Sales by Country (2025-2030) & (K Units)
Table 59. Europe Diabetes Testing Program Sales by Type (2019-2024) & (K Units)
Table 60. Europe Diabetes Testing Program Sales by Type (2025-2030) & (K Units)
Table 61. Europe Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million)
Table 62. Europe Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million)
Table 63. Europe Diabetes Testing Program Sales by Application (2019-2024) & (K Units)
Table 64. Europe Diabetes Testing Program Sales by Application (2025-2030) & (K Units)
Table 65. Europe Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million)
Table 66. Europe Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million)
Table 67. Europe Diabetes Testing Program Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 68. Europe Diabetes Testing Program Revenue by Country (2019-2024) & (US$ Million)
Table 69. Europe Diabetes Testing Program Revenue by Country (2025-2030) & (US$ Million)
Table 70. Europe Diabetes Testing Program Sales by Country (2019-2024) & (K Units)
Table 71. Europe Diabetes Testing Program Sales by Country (2025-2030) & (K Units)
Table 72. China Diabetes Testing Program Sales by Type (2019-2024) & (K Units)
Table 73. China Diabetes Testing Program Sales by Type (2025-2030) & (K Units)
Table 74. China Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million)
Table 75. China Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million)
Table 76. China Diabetes Testing Program Sales by Application (2019-2024) & (K Units)
Table 77. China Diabetes Testing Program Sales by Application (2025-2030) & (K Units)
Table 78. China Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million)
Table 79. China Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million)
Table 80. Asia Diabetes Testing Program Sales by Type (2019-2024) & (K Units)
Table 81. Asia Diabetes Testing Program Sales by Type (2025-2030) & (K Units)
Table 82. Asia Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million)
Table 83. Asia Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million)
Table 84. Asia Diabetes Testing Program Sales by Application (2019-2024) & (K Units)
Table 85. Asia Diabetes Testing Program Sales by Application (2025-2030) & (K Units)
Table 86. Asia Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million)
Table 87. Asia Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million)
Table 88. Asia Diabetes Testing Program Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 89. Asia Diabetes Testing Program Revenue by Region (2019-2024) & (US$ Million)
Table 90. Asia Diabetes Testing Program Revenue by Region (2025-2030) & (US$ Million)
Table 91. Asia Diabetes Testing Program Sales by Region (2019-2024) & (K Units)
Table 92. Asia Diabetes Testing Program Sales by Region (2025-2030) & (K Units)
Table 93. Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2019-2024) & (K Units)
Table 94. Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2019-2024) & (US$ Million)
Table 96. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2025-2030) & (US$ Million)
Table 97. Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2019-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2025-2030) & (K Units)
Table 99. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2019-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2025-2030) & (US$ Million)
Table 101. Middle East, Africa and Latin America Diabetes Testing Program Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 102. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2019-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2025-2030) & (K Units)
Table 106. Abbott Laboratories Company Information
Table 107. Abbott Laboratories Description and Major Businesses
Table 108. Abbott Laboratories Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Abbott Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Abbott Laboratories Recent Developments
Table 111. Roche Company Information
Table 112. Roche Description and Major Businesses
Table 113. Roche Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Roche Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Roche Recent Developments
Table 116. Siemens Company Information
Table 117. Siemens Description and Major Businesses
Table 118. Siemens Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Siemens Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Siemens Recent Developments
Table 121. LifeScan Company Information
Table 122. LifeScan Description and Major Businesses
Table 123. LifeScan Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. LifeScan Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Bio-Rad Laboratories Company Information
Table 126. Bio-Rad Laboratories Description and Major Businesses
Table 127. Bio-Rad Laboratories Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Bio-Rad Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bio-Rad Laboratories Recent Developments
Table 130. Sinocare Company Information
Table 131. Sinocare Description and Major Businesses
Table 132. Sinocare Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Sinocare Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Tosoh Company Information
Table 135. Tosoh Description and Major Businesses
Table 136. Tosoh Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Tosoh Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Tosoh Recent Developments
Table 139. Ascensia Company Information
Table 140. Ascensia Description and Major Businesses
Table 141. Ascensia Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Ascensia Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Danaher Corporation Company Information
Table 144. Danaher Corporation Description and Major Businesses
Table 145. Danaher Corporation Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Danaher Corporation Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Danaher Corporation Recent Developments
Table 148. Trinity Biotech Company Information
Table 149. Trinity Biotech Description and Major Businesses
Table 150. Trinity Biotech Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. Trinity Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Trinity Biotech Recent Developments
Table 153. Acon Biotech Company Information
Table 154. Acon Biotech Description and Major Businesses
Table 155. Acon Biotech Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 156. Acon Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Terumo Company Information
Table 158. Terumo Description and Major Businesses
Table 159. Terumo Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Terumo Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Terumo Recent Developments
Table 162. Arkray Company Information
Table 163. Arkray Description and Major Businesses
Table 164. Arkray Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Arkray Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. HUMAN Diagnostics Company Information
Table 167. HUMAN Diagnostics Description and Major Businesses
Table 168. HUMAN Diagnostics Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. HUMAN Diagnostics Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Braun Company Information
Table 171. Braun Description and Major Businesses
Table 172. Braun Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Braun Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Braun Recent Developments
Table 175. I-SENS Company Information
Table 176. I-SENS Description and Major Businesses
Table 177. I-SENS Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. I-SENS Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. I-SENS Recent Developments
Table 180. Omron Company Information
Table 181. Omron Description and Major Businesses
Table 182. Omron Diabetes Testing Program Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Omron Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Omron Recent Developments
Table 185. Raw Materials Key Suppliers Lists
Table 186. Diabetes Testing Program Distributors List
Table 187. Diabetes Testing Program Customers List
Table 188. Diabetes Testing Program Market Trends
Table 189. Diabetes Testing Program Market Drivers
Table 190. Diabetes Testing Program Market Challenges
Table 191. Diabetes Testing Program Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources

List of Figures

Figure 1. Diabetes Testing Program Product Picture
Figure 2. Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Diabetes Testing Program Market Share by Type: 2023 & 2030
Figure 4. HbA1c Test Product Picture
Figure 5. Major Manufacturers of HbA1c Test
Figure 6. Finger-prick Test Product Picture
Figure 7. Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Diabetes Testing Program Market Share by Application: 2023 & 2030
Figure 9. Medical Diagnosis
Figure 10. Home Test
Figure 11. Lab Testing
Figure 12. Diabetes Testing Program Report Years Considered
Figure 13. Global Diabetes Testing Program Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 15. Global Diabetes Testing Program Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 16. Global Diabetes Testing Program Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Diabetes Testing Program Revenue Market Share by Region (2019-2030)
Figure 18. Global Diabetes Testing Program Sales (2019-2030) & (K Units)
Figure 19. Global Diabetes Testing Program Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 20. Global Diabetes Testing Program Sales Market Share by Region (2019-2030)
Figure 21. US & Canada Diabetes Testing Program Sales YoY (2019-2030) & (K Units)
Figure 22. US & Canada Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Europe Diabetes Testing Program Sales YoY (2019-2030) & (K Units)
Figure 24. Europe Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million)
Figure 25. China Diabetes Testing Program Sales YoY (2019-2030) & (K Units)
Figure 26. China Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Asia (excluding China) Diabetes Testing Program Sales YoY (2019-2030) & (K Units)
Figure 28. Asia (excluding China) Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Diabetes Testing Program Sales YoY (2019-2030) & (K Units)
Figure 30. Middle East, Africa and Latin America Diabetes Testing Program Revenue YoY (2019-2030) & (US$ Million)
Figure 31. Global Diabetes Testing Program Sales Share by Manufacturers (2023)
Figure 32. The Diabetes Testing Program Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. Global Diabetes Testing Program Revenue Share by Manufacturers (2023)
Figure 34. The Top 5 and 10 Largest Manufacturers of Diabetes Testing Program in the World: Market Share by Diabetes Testing Program Revenue in 2023
Figure 35. Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 36. Global Diabetes Testing Program Sales Market Share by Type (2019-2030)
Figure 37. Global Diabetes Testing Program Revenue Market Share by Type (2019-2030)
Figure 38. Global Diabetes Testing Program Sales Market Share by Application (2019-2030)
Figure 39. Global Diabetes Testing Program Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Diabetes Testing Program Sales Market Share by Type (2019-2030)
Figure 41. US & Canada Diabetes Testing Program Revenue Market Share by Type (2019-2030)
Figure 42. US & Canada Diabetes Testing Program Sales Market Share by Application (2019-2030)
Figure 43. US & Canada Diabetes Testing Program Revenue Market Share by Application (2019-2030)
Figure 44. US & Canada Diabetes Testing Program Revenue Share by Country (2019-2030)
Figure 45. US & Canada Diabetes Testing Program Sales Share by Country (2019-2030)
Figure 46. US Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 47. Canada Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 48. Europe Diabetes Testing Program Sales Market Share by Type (2019-2030)
Figure 49. Europe Diabetes Testing Program Revenue Market Share by Type (2019-2030)
Figure 50. Europe Diabetes Testing Program Sales Market Share by Application (2019-2030)
Figure 51. Europe Diabetes Testing Program Revenue Market Share by Application (2019-2030)
Figure 52. Europe Diabetes Testing Program Revenue Share by Country (2019-2030)
Figure 53. Europe Diabetes Testing Program Sales Share by Country (2019-2030)
Figure 54. Germany Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 55. France Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 56. U.K. Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 57. Italy Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 58. Russia Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 59. China Diabetes Testing Program Sales Market Share by Type (2019-2030)
Figure 60. China Diabetes Testing Program Revenue Market Share by Type (2019-2030)
Figure 61. China Diabetes Testing Program Sales Market Share by Application (2019-2030)
Figure 62. China Diabetes Testing Program Revenue Market Share by Application (2019-2030)
Figure 63. Asia Diabetes Testing Program Sales Market Share by Type (2019-2030)
Figure 64. Asia Diabetes Testing Program Revenue Market Share by Type (2019-2030)
Figure 65. Asia Diabetes Testing Program Sales Market Share by Application (2019-2030)
Figure 66. Asia Diabetes Testing Program Revenue Market Share by Application (2019-2030)
Figure 67. Asia Diabetes Testing Program Revenue Share by Region (2019-2030)
Figure 68. Asia Diabetes Testing Program Sales Share by Region (2019-2030)
Figure 69. Japan Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 70. South Korea Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 72. India Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 73. Australia Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Diabetes Testing Program Sales Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Diabetes Testing Program Revenue Market Share by Type (2019-2030)
Figure 76. Middle East, Africa and Latin America Diabetes Testing Program Sales Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Diabetes Testing Program Revenue Market Share by Application (2019-2030)
Figure 78. Middle East, Africa and Latin America Diabetes Testing Program Revenue Share by Country (2019-2030)
Figure 79. Middle East, Africa and Latin America Diabetes Testing Program Sales Share by Country (2019-2030)
Figure 80. Brazil Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 81. Mexico Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 82. Turkey Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 83. Israel Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 84. GCC Countries Diabetes Testing Program Revenue (2019-2030) & (US$ Million)
Figure 85. Diabetes Testing Program Value Chain
Figure 86. Diabetes Testing Program Production Process
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Global Diabetes Testing Program Market Insights, Forecast to 2030

Description

Table of Contents

List of Tables

Table of Contents

1 STUDY COVERAGE

2 EXECUTIVE SUMMARY

3 COMPETITION BY MANUFACTURERS

4 MARKET SIZE BY TYPE

5 MARKET SIZE BY APPLICATION

6 US & CANADA

7 EUROPE

8 CHINA

9 ASIA (EXCLUDING CHINA)

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

11 CORPORATE PROFILE

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

13 DIABETES TESTING PROGRAM MARKET DYNAMICS

14 KEY FINDINGS IN THE GLOBAL DIABETES TESTING PROGRAM STUDY

15 APPENDIX

List of Tables

List of Figures